Thürlimann, Beat

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 25.

Journal Article

Leone, Jose P; Cole, Bernard F; Regan, Meredith M; Thürlimann, Beat; Coates, Alan S; Rabaglio, Manuela; Giobbie-Hurder, Anita; Gelber, Richard D; Ejlertsen, Bent; Harvey, Vernon J; Neven, Patrick; Láng, Istvan; Bonnefoi, Herve; Wardley, Andrew; Goldhirsch, Aron; Di Leo, Angelo; Colleoni, Marco; Vaz-Luis, Ines; Lin, Nancy U (2021). Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial. Cancer, 127(5), pp. 700-708. Wiley 10.1002/cncr.33318

Rabaglio, Manuela; Sun, Zhuoxin; Maibach, Rudolf; Giobbie-Hurder, Anita; Ejlertsen, Bent; Harvey, Vernon J; Neven, Patrick; Láng, István; Bonnefoi, Hervé; Wardley, Andrew; Ruepp, Barbara; Castiglione, Monica; Coates, Alan S; Gelber, Richard D; Goldhirsch, Aron; Colleoni, Marco; Thürlimann, Beat; Regan, Meredith M (2020). Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial. Breast cancer research and treatment, 185(3), pp. 697-707. Springer 10.1007/s10549-020-05981-z

Hoemme, Alexander; Barth, Holger; Haschke, Manuel Martin; Krähenbühl, Stephan; Strasser, Florian; Lehner, Claudia; von Kameke, Alexander; Wälti, Thomas; Thürlimann, Beat; Früh, Martin; Driessen, Christoph; Joerger, Markus (2019). Prognostic impact of polypharmacy and drug interactions in patients with advanced cancer. Cancer chemotherapy and pharmacology, 83(4), pp. 763-774. Springer 10.1007/s00280-019-03783-9

Wapnir, Irene L.; Price, Karen N.; Anderson, Stewart J.; Robidoux, André; Martín, Miguel; Nortier, Johan W.R.; Paterson, Alexander H.G.; Rimawi, Mothaffar F.; Láng, István; Baena-Cañada, José Manuel; Thürlimann, Beat; Mamounas, Eleftherios P.; Geyer, Charles E.; Gelber, Shari; Coates, Alan S.; Gelber, Richard D.; Rastogi, Priya; Regan, Meredith M.; Wolmark, Norman and Aebi, Stefan (2018). Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial. Journal of clinical oncology, 36(11), pp. 1073-1079. American Society of Clinical Oncology 10.1200/JCO.2017.76.5719

Zweifel, Martin; Thürlimann, Beat; Riniker, Salome; Weder, Patrik; von Moos, Roger; Pagani, Olivia; Bigler, Martin; Rothgiesser, Karin M; Pilop, Christiane; Hawle, Hanne; Brauchli, Peter; Tapia, Coya; Schoenfeld, Wolfgang; Sessa, Cristiana (2017). Phase I trial of the androgen receptor modulator CR1447 in breast cancer patients. Endocrine Connections, 6(7), pp. 549-556. BioScientifica 10.1530/EC-17-0174

Borgquist, Signe; Giobbie-Hurder, Anita; Ahern, Thomas P; Garber, Judy E; Colleoni, Marco; Láng, István; Debled, Marc; Ejlertsen, Bent; von Moos, Roger; Smith, Ian; Coates, Alan S; Goldhirsch, Aron; Rabaglio, Manuela; Price, Karen N; Gelber, Richard D; Regan, Meredith M; Thürlimann, Beat (2017). Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study. Journal of clinical oncology, 35(11), pp. 1179-1188. American Society of Clinical Oncology 10.1200/JCO.2016.70.3116

Chirgwin, Jacquie H; Giobbie-Hurder, Anita; Coates, Alan S; Price, Karen N; Ejlertsen, Bent; Debled, Marc; Gelber, Richard D; Goldhirsch, Aron; Smith, Ian; Rabaglio, Manuela; Forbes, John F; Neven, Patrick; Láng, István; Colleoni, Marco; Thürlimann, Beat (2016). Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence. Journal of clinical oncology, 34(21), pp. 2452-2459. American Society of Clinical Oncology 10.1200/JCO.2015.63.8619

Huwiler, Karin; Thürlimann, Beat; Cerny, Thomas; Zwahlen, Marcel (2015). Comment on: ‘Screening’ for Breast Cancer: Misguided Research Misinforming Public Policies, by O. S. Miettinen. Epidemiologic Methods, 4(1), pp. 15-8. De Gruyter 10.1515/em-2015-0022

Decensi, Andrea; Sun, Zhuoxin; Guerrieri-Gonzaga, Aliana; Thürlimann, Beat; McIntosh, Christina; Tondini, Carlo; Monnier, Alain; Campone, Mario; Debled, Marc; Schönenberger, Astrid; Zaman, Khalil; Johansson, Harriet; Price, Karen N; Gelber, Richard D.; Goldhirsch, Aron; Coates, Alan S.; Aebi, Stefan (2014). Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences. Breast cancer research and treatment, 144(2), pp. 321-329. Springer 10.1007/s10549-014-2849-2

Aebi, Stefan; Gelber, Shari; Anderson, Stewart J.; Láng, István; Robidoux, André; Martín, Miguel; Nortier, Johan W. R.; Paterson, Alexander H. G.; Rimawi, Mothaffar F.; Cañada, José Manuel Baena; Thürlimann, Beat; Murray, Elizabeth; Mamounas, Eleftherios P.; Geyer, Charles E.; Price, Karen N.; Coates, Alan S.; Gelber, Richard D.; Rastogi, Priya; Wolmark, Norman and Wapnir, Irene L. (2014). Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial. The lancet oncology, 15(2), pp. 156-163. Elsevier 10.1016/S1470-2045(13)70589-8

Ewertz, Marianne; Gray, Kathryn P; Regan, Meredith M; Ejlertsen, Bent; Price, Karen N; Thürlimann, Beat; Bonnefoi, Hervé; Forbes, John F; Paridaens, Robert J; Rabaglio, Manuela; Gelber, Richard D; Colleoni, Marco; Láng, István; Smith, Ian E; Coates, Alan S; Goldhirsch, Aron; Mouridsen, Henning T (2012). Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial. Journal of clinical oncology, 30(32), pp. 3967-75. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2011.40.8666

Regan, Meredith M.; Leyland-Jones, Brian; Bouzyk, Mark; Pagani, Olivia; Tang, Weining; Kammler, Roswitha; Dell’Orto, Patrizia; Biasi, Maria Olivia; Thürlimann, Beat; Lyng, Maria B.; Ditzel, Henrik J.; Neven, Patrick; Debled, Marc; Maibach, Rudolf; Price, Karen N.; Gelber, Richard D.; Coates, Alan S.; Goldhirsch, Aron; Rae, James M. and Viale, Giuseppe (2012). CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial. Journal of the National Cancer Institute JNCI, 104(6), pp. 441-451. Oxford University Press 10.1093/jnci/djs125

Regan, Meredith M; Neven, Patrick; Giobbie-Hurder, Anita; Goldhirsch, Aron; Ejlertsen, Bent; Mauriac, Louis; Forbes, John F; Smith, Ian; Láng, István; Wardley, Andrew; Rabaglio, Manuela; Price, Karen N; Gelber, Richard D; Coates, Alan S; Thürlimann, Beat; BIG 1-98 Collaborative Group, ; International Breast Cancer Study Group (IBCSG), (2011). Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. Lancet oncology, 12(12), pp. 1101-8. Oxford: Elsevier 10.1016/S1470-2045(11)70270-4

Phillips, Kelly-Anne; Aldridge, Julie; Ribi, Karin; Sun, Zhuoxin; Thompson, Alastair; Harvey, Vernon; Thürlimann, Beat; Cardoso, Fatima; Pagani, Olivia; Coates, Alan S; Goldhirsch, Aron; Price, Karen N; Gelber, Richard D; Bernhard, Jürg (2011). Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial. Breast cancer research and treatment, 126(1), pp. 221-6. Dordrecht: Springer US; http://www.springer-ny.com 10.1007/s10549-010-1235-y

Regan, Meredith M.; Price, Karen N.; Giobbie-Hurder, Anita; Thürlimann, Beat; Gelber, Richard D. (2011). Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer. Breast cancer research, 2011(13 (3)), p. 209. London: BioMed Central Ltd. 10.1186/bcr2837

Huober, Jens; Baumann, Michael; Rochlitz, Christoph; Aebi, Stefan; Güth, Uwe; von Moos, Roger; Müller, Andreas; von Rohr, Lukas; Widmer, Isabelle; Thürlimann, Beat (2011). Trastuzumab treatment beyond progression in advanced breast cancer: patterns of care in six Swiss breast cancer centers. Oncology - international journal of cancer research and treatment, 81(3-4), pp. 160-166. Karger 10.1159/000333396

Antonov, Janine; Popovici, Vlad; Delorenzi, Mauro; Wirapati, Pratyaksha; Baltzer, Anna; Oberli, Andrea; Thürlimann, Beat; Giobbie-Hurder, Anita; Viale, Giuseppe; Altermatt, Hans Jörg; Aebi, Stefan; Jaggi, Rolf (2010). Molecular risk assessment of BIG 1-98 participants by expression profiling using RNA from archival tissue. BMC cancer, 10, p. 37. London: BioMed Central 10.1186/1471-2407-10-37

Phillips, Kelly-Anne; Ribi, Karin; Sun, Zhuoxin; Stephens, Alisa; Thompson, Alastair; Harvey, Vernon; Thürlimann, Beat; Cardoso, Fatima; Pagani, Olivia; Coates, Alan S; Goldhirsch, Aron; Price, Karen N; Gelber, Richard D; Bernhard, Jürg (2010). Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial. Breast, 19(5), pp. 388-95. Amsterdam: Elsevier 10.1016/j.breast.2010.03.025

Pagani, Olivia; Gelber, Shari; Simoncini, Edda; Castiglione-Gertsch, Monica; Price, Karen; Gelber, Richard; Holmberg, Stig; Crivellari, Diana; Collins, John; Lindtner, Jurij; Thürlimann, Beat; Fey, Martin; Murray, Elizabeth; Forbes, John; Coates, Alan; Goldhirsch, Aron (2009). Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93. Breast cancer research and treatment, 116(3), pp. 491-500. Dordrecht: Springer 10.1007/s10549-008-0225-9

Pagani, Olivia; Price, Karen N; Gelber, Richard D; Castiglione-Gertsch, Monica; Holmberg, Stig B; Lindtner, Jurij; Thürlimann, Beat; Collins, John; Fey, Martin F; Coates, Alan S; Goldhirsch, Aron (2009). Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century. Breast cancer research and treatment, 117(2), pp. 319-24. Dordrecht: Springer 10.1007/s10549-008-0282-0

Crivellari, Diana; Sun, Zhuoxin; Coates, Alan S; Price, Karen N; Thürlimann, Beat; Mouridsen, Henning; Mauriac, Louis; Forbes, John F; Paridaens, Robert J; Castiglione-Gertsch, Monica; Gelber, Richard D; Colleoni, Marco; Láng, István; Del Mastro, Lucia; Gladieff, Laurence; Rabaglio, Manuela; Smith, Ian E; Chirgwin, Jacquie H; Goldhirsch, Aron (2008). Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial. Journal of clinical oncology, 26(12), pp. 1972-9. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2007.14.0459

Karlsson, Per; Cole, Bernard F; Price, Karen N; Coates, Alan S; Castiglione-Gertsch, Monica; Gusterson, Barry A; Murray, Elizabeth; Lindtner, Jurij; Collins, John P; Holmberg, Stig B; Fey, Martin F; Thürlimann, Beat; Crivellari, Diana; Forbes, John F; Gelber, Richard D; Goldhirsch, Aron; Wallgren, Arne (2007). The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer. Journal of clinical oncology, 25(15), pp. 2019-26. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2006.09.8152

Mouridsen, Henning; Keshaviah, Aparna; Coates, Alan S; Rabaglio, Manuela; Castiglione-Gertsch, Monica; Sun, Zhuoxin; Thürlimann, Beat; Mauriac, Louis; Forbes, John F; Paridaens, Robert; Gelber, Richard D; Colleoni, Marco; Smith, Ian; Price, Karen N; Goldhirsch, Aron (2007). Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial. Journal of clinical oncology, 25(36), pp. 5715-22. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2007.12.1665

Glaus, Agnes; Boehme, Christel; Thürlimann, Beat; Ruhstaller, Thomas; Hsu, Shu-Fang; Morant, Rudolf; Senn, Hans-Jörg; von Moos, Roger (2006). Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment. Annals of oncology, 17(5), pp. 801-806. Oxford: Oxford University Press 10.1093/annonc/mdl030

Sabbioni, Marzio E E; Bernhard, Jürg; Siegrist, Hans-Peter; Schmitz, Shu-Fang Hsu; Gertsch, Monica Castiglione; Thürlimann, Beat; Bonnefoi, Hervé; Perey, Lucien; Herrmann, Richard; Goldhirsch, Aron; Hürny, Christoph; Swiss Group for Clinical Cancer Research, (SAKK) (2004). Does subjective burden of early breast cancer and its treatment affect immune measures during adjuvant therapy? Breast cancer research and treatment, 87(1), pp. 75-86. Dordrecht: Springer 10.1023/B:BREA.0000041584.53863.a7

This list was generated on Thu Mar 28 14:58:36 2024 CET.
Provide Feedback